Anavex Life Sciences Corp (AVXL)

[Steady_T]

The peer review paper is largely out of their control. The process can take months or a year. Once the paper is accepted for publishing it is up to the publisher as to when it will be published. The publisher can hold the paper for a theme edition for example or choose to get in the next edition as important information.

So I suggest decoupling the paper from the rest of the events as you think about the company. Yes having a paper published on Monday with great results would be most desirable. But as we have seen with the Rett results, the paper may not be the very positive outcome we hope for.

Overall the fate of the company is determined by approval for an indication. That approval is determined by the trial results and the agencies opinion on those results.

Basically we investors are along for the ride. The choices are simple. Stay or go.